RT Journal Article
SR Electronic
T1 KUL@SMM4H’23: Text Augmentations with R-drop for Classification of Tweets Self Reporting Covid-19
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.11.06.23298151
DO 10.1101/2023.11.06.23298151
A1 Francis, Sumam
A1 Moens, Marie-Francine
YR 2023
UL http://medrxiv.org/content/early/2023/11/07/2023.11.06.23298151.abstract
AB This paper presents models created for the Social Media Mining for Health 2023 shared task. Our team addressed the first task, classifying tweets that self-report Covid-19 diagnosis. Our approach involves a classification model that incorporates diverse textual augmentations and utilizes R-drop to augment data and mitigate overfitting, boosting model efficacy. Our leading model, enhanced with R-drop and augmentations like synonym substitution, reserved words, and back translations, outperforms the task mean and median scores. Our system achieves an impressive F1 score of 0.877 on the test set.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFWO G0H6820N CHIST-ERA ANTIDOTEAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The dataset used as part of the work was obtained after registering with the SMM4H 2023 workshop shared TASK1. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe data used for the work was obtained from SMM4H 2023 Task 1 workshop organisers after registering to participate in it.